- Home
- SBCF vs RGC Comparison
SBCF vs RGC Comparison
Compare SBCF & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SBCF | RGC |
|---|---|---|
| Founded | 1926 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.1B |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SBCF | RGC |
|---|---|---|
| Price | $35.57 | $5.06 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $38.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 220.6K |
| Earning Date | 04-28-2026 | 10-31-2025 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | ★ 10.56 | N/A |
| EPS | ★ 0.84 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $45.04 | N/A |
| Revenue Next Year | $6.30 | N/A |
| P/E Ratio | $42.11 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.96 | $4.51 |
| 52 Week High | $35.64 | $69.00 |
Technical Indicators
Market Signals| Indicator | SBCF | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 67.00 | 32.01 |
| Support Level | $31.01 | $4.51 |
| Resistance Level | N/A | $6.53 |
| Average True Range (ATR) | 0.86 | 0.56 |
| MACD | 0.05 | 0.30 |
| Stochastic Oscillator | 97.87 | 9.51 |
Price Performance
Historical ComparisonAbout SBCF Seacoast Banking Corporation of Florida
Seacoast Banking Corp of Florida is a holding company. The company provides integrated financial services, including commercial and consumer banking, wealth management, and mortgage and insurance services, to customers across Florida through branch, mobile, and online banking solutions. It maintains day-to-day operations, particularly in the areas of operations, treasury management systems, information technology, and security. The company has one reportable segment that provides these integrated financial services, with segment revenues driven mainly by interest and fees on loans, interest on cash and cash equivalents, and investment securities, and fees on depository products and services.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.